Cargando…

Effectiveness and safety of common therapeutic drugs for refractory lupus nephritis: A network meta-analysis

Previous studies have indicated that various drugs may be beneficial for the treatment of patients with refractory lupus nephritis (RLN). The present study aimed to evaluate the effectiveness and safety of common therapeutic drugs for the treatment of RLN using a network meta-analysis (NMA). NMA was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Jun, Tao, Meng-Jun, Jin, Lai-Run, Sheng, Jun, Li, Zhi, Peng, Hui, Xu, Liang, Yuan, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923745/ https://www.ncbi.nlm.nih.gov/pubmed/31897105 http://dx.doi.org/10.3892/etm.2019.8257

Ejemplares similares

The safety and efficacy of biologic agents in treatment of systemic lupus erythematosus: A network meta-analysis
por: Tao, Meng-Jun, et al.
Publicado: (2019)

Secukinumab on Refractory Lupus Nephritis
por: Costa, Rita, et al.
Publicado: (2021)

Experience with abatacept in refractory lupus nephritis
por: Calatayud, Emma, et al.
Publicado: (2023)

Daratumumab monotherapy for refractory lupus nephritis
por: Roccatello, Dario, et al.
Publicado: (2023)

Management of refractory lupus nephritis: challenges and solutions
por: Yo, JH, et al.
Publicado: (2019)

Rituximab can Decrease Proteinuria in Refractory Lupus Nephritis
por: Suh, Chang-Hee
Publicado: (2022)

Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus and lupus nephritis who are refractory to conventional therapy
por: Tanaka, Yoshiya, et al.
Publicado: (2016)

Efficacy and safety of Iguratimod as an add-on therapy for refractory lupus nephritis: A preliminary investigational study
por: Yan, Qingran, et al.
Publicado: (2023)

Accelerated Glomerular Cell Senescence in Experimental Lupus Nephritis
por: Yang, Chen, et al.
Publicado: (2018)

Endoplasmic Reticulum Stress in Systemic Lupus Erythematosus and Lupus Nephritis: Potential Therapeutic Target
por: Li, Hui-Yuan, et al.
Publicado: (2023)

Clinical efficacy and safety of rituximab in lupus nephritis
por: Zhong, Zhiqing, et al.
Publicado: (2019)

Biomarkers for Refractory Lupus Nephritis: A Microarray Study of Kidney Tissue
por: Benjachat, Thitima, et al.
Publicado: (2015)

Low-Dose Interleukin-2 as an Alternative Therapy for Refractory Lupus Nephritis
por: Zhang, Xia, et al.
Publicado: (2021)

Treatment of refractory lupus nephritis using leflunomide: A prospective study
por: Zhang, Shuo, et al.
Publicado: (2023)

A new promising biological agent for refractory lupus nephritis: Telitacicept
por: Liu, Shuangyan, et al.
Publicado: (2023)

Metabolic syndrome in systemic lupus erythematosus was closely related to body mass index, blood pressure, blood sugar, blood lipids, and arthritis
por: Jin, Lai-Run, et al.
Publicado: (2020)

Comparative Efficacy and Safety of Biological Agents in the Treatment of Lupus Nephritis: A Network Meta-Analysis
por: Lee, Young Ho, et al.
Publicado: (2023)

Biomarkers Associated with Drugs for the Treatment of Lupus Nephritis
por: Nie, Huiyu, et al.
Publicado: (2023)

Revisited Cyclophosphamide in the Treatment of Lupus Nephritis
por: Quan, Xiao-ying, et al.
Publicado: (2022)

Comparative Effectiveness of Rituximab and Common Induction Therapies for Lupus Nephritis: A Systematic Review and Network Meta-Analysis
por: Li, Kang, et al.
Publicado: (2022)

Novel Autoantigens Associated with Lupus Nephritis
por: Onishi, Sachiko, et al.
Publicado: (2015)

Rituximab is effective in the treatment of nephritis in lupus patients, refractory to conventional immunosuppressive therapy
por: Martínez, R, et al.
Publicado: (2010)

Therapeutic Effect of Dendrobium candidum on Lupus Nephritis in Mice
por: Wang, Qiang, et al.
Publicado: (2017)

Novel Therapeutics for Management of Lupus Nephritis: What Is Next?
por: Thakare, Sayali B., et al.
Publicado: (2023)

Efficacy and safety of immunosuppressive agents for adults with lupus nephritis: a systematic review and network meta-analysis
por: Jiang, Nan, et al.
Publicado: (2023)

Efficacy and Safety of Biologic Agents for Lupus Nephritis: A Systematic Review and Meta-analysis
por: Chen, Pang, et al.
Publicado: (2023)

Efficacy and safety of belimumab therapy in lupus nephritis: a systematic review and meta-analysis
por: Zhang, Han, et al.
Publicado: (2023)

Hydroxychloroquine administration exacerbates acute kidney injury complicated by lupus nephritis
por: An, Ning, et al.
Publicado: (2022)

Safety and efficacy of rituximab in refractory pediatric Systemic Lupus Erythematosus nephritis: a single-center experience of northern Greece
por: Trachana, M, et al.
Publicado: (2011)

The Network of Inflammatory Mechanisms in Lupus Nephritis
por: Nozaki, Yuji
Publicado: (2020)

Integrative medicine for managing the symptoms of lupus nephritis: A protocol for systematic review and meta-analysis
por: Choi, Tae-Young, et al.
Publicado: (2018)

The Pathogenesis of Lupus Nephritis
por: Sterner, Rosalie M., et al.
Publicado: (2014)

Pediatric lupus nephritis
por: Pinheiro, Sergio Veloso Brant, et al.
Publicado: (2018)

Hyperhomocysteinemia and Lupus Nephritis
por: Timlin, Homa, et al.
Publicado: (2019)

Management of Lupus Nephritis
por: Tamirou, Farah, et al.
Publicado: (2021)

Lupus Nephritis and Dysbiosis
por: Monticolo, Marta, et al.
Publicado: (2023)

O07 Managing relapsing and refractory lupus nephritis in juvenile systemic lupus erythematosus: a case report
por: Javed, Farhan, et al.
Publicado: (2021)

Comparative effectiveness of immunosuppressive drugs and corticosteroids for lupus nephritis: a systematic review and network meta-analysis
por: Singh, Jasvinder A., et al.
Publicado: (2016)

Efficacy and safety of tacrolimus in induction therapy of patients with lupus nephritis
por: Zhou, Tianbiao, et al.
Publicado: (2019)

IGFBP2 function as a novel biomarker for active lupus nephritis
por: Li, Hui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6nmg264ku01r7v0ui0s4dkmklt